Honey Naturals Signs Agreement With Les Walgreen of Peaux Deaux Products, Division of Invicta Group, to Represent the ZarBee's Children Cough Syrup
ZarBee's Is a Safe and Effective Children's Cough Medicine to Replace the Recent Recalled Medicines
CHICAGO, IL, Jun 02, 2010 (MARKETWIRE via COMTEX) -- Invicta Group Inc. (http://www.ivitgroup.com) (PINKSHEETS: IVIT) is pleased to announce the signing of an agreement with Honey Naturals with Les Walgreen, President of Peaux Deaux Products, a division of the Invicta Group to represent the ZarBee's Children Cough Syrup.
ZarBee's(TM) Children's Cough Syrup is an all-natural, honey-based cough suppressant that provides children relief from coughs while simultaneously boosting the immune system. The product is made with a unique blend of dark honey, vitamins and other all natural ingredients. ZarBee's does not contain any Dextromethorphan or alcohol and is safe for children 12 months and older. It is high in antioxidants and contains the daily vitamin C requirements per dose. Pediatricians recommend it and you can find out more at www.Zarbees.com.
Les Walgreen said, "As we have seen a recent recall of DM children's medicines, parents have nowhere to turn to. Those medications (DM) already were marked unsafe for children 4 and under. Finally, there is a safe and effective treatment for young children! I expect a resounding response from retailers that can now offer ZarBee's on their shelves. Parents, get ready, ZarBee's will be there for you and your children!"
CEO of the Invicta Group, Paul Sorkin, said, "We represent products and companies that we believe in and I have been very impressed with how safe and effective ZarBee's is. Parents are always looking for alternatives to some of the dangerous or unproven products or remedies out there today and we are proud to represent this product. As an additional benefit our shareholders should also be happy that we are continuing to add quality clients and products which will help us increase both our revenues and profits."...
No comments:
Post a Comment